No Detail Found!

Efficacy of antimoniate antimoniate leishmaniasis

Author(s)
Jamshida Iqbal Khattak Department of Dermatology, Hayatabad Medical Complex, Peshawar, Pakistan
Ghafoor Ullah Department of Dermatology, Hayatabad Medical Complex, Peshawar, Pakistan
Qamar uddin Khan Combined Military Hospital, Jehlum, Pakistan
Abstract
Objective To compare the efficacy of combined parenteral Meglumine Antimoniate and oral Allopurinol with Meglumine Antimoniate alone in the treatment of Cutaneous Leishmaniasis. Study Design Randomized controlled trial. Place and duration of study Department of Dermatology, Combined Military Hospital, Peshawar from May 2016- Oct 2016. Methods A total of 112 patients presenting with Cutaneous leishmaniasis were included in the study and randomly allocated in two groups. In group I participants received combined therapy with oral allopurinol 15mg/kg/day and parenteral meglumine antimoniate 15mg/kg/day while group II participants received only meglumine antimoniate 15mg/kg/day. Follow up was done at 8th week and results were recorded. Results The mean age of the whole study sample was 27.4±4.6 years. In group I the efficacy was observed in 83.9% of patients compared to 73.2% in group II (p 0.167). Conclusion Our study concluded that the combination therapy (MA plus CL) is more effective in treating CL than isolation therapy with MA alone. More randomized controlled trials with larger sample sizes are highly recommended to draw more conclusive results and generate further evidence for uniform decision making in the treatment of CL.
Publication Details
Page(s) 644-649
DOI DOI not available
Published Journal: Journal of Pakistan Association of Dermatologists, Volume: 30, Issue: 4, Year: 2020

Request the full text from PASTIC

Keywords
Cutaneous leishmaniasis, maglumine antimoniate, allopurinol
0

Citations

0

Downloads

110

Views